Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
Lorusso, D., Ferrandina, G., Pignata, S., Ludovisi, M., Vigano, R., Scalone, S., Scollo, P., Breda, E., Pietragalla, A., Scambia, G.Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp266
Date:
January, 2010
File:
PDF, 80 KB
english, 2010